These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Examination of cell-host-biomaterial interactions via high-throughput technologies: A re-appraisal. Power KA; Fitzgerald KT; Gallagher WM Biomaterials; 2010 Sep; 31(26):6667-74. PubMed ID: 20557931 [TBL] [Abstract][Full Text] [Related]
4. Rethinking regenerative medicine: a macrophage-centered approach. Brown BN; Sicari BM; Badylak SF Front Immunol; 2014; 5():510. PubMed ID: 25408693 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics-based selection of a model cell type for in vitro biomaterial testing. Groen N; van de Peppel J; Yuan H; van Leeuwen JP; van Blitterswijk CA; de Boer J Biomaterials; 2013 Jul; 34(22):5552-61. PubMed ID: 23632322 [TBL] [Abstract][Full Text] [Related]
6. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Franz S; Rammelt S; Scharnweber D; Simon JC Biomaterials; 2011 Oct; 32(28):6692-709. PubMed ID: 21715002 [TBL] [Abstract][Full Text] [Related]
7. Migration assay to evaluate cellular interactions with biomaterials for tissue engineering/regenerative medicine applications. Guthrie KI; Sangha N; Genheimer CW; Basu J; Ludlow JW Methods Mol Biol; 2013; 1001():189-96. PubMed ID: 23494430 [TBL] [Abstract][Full Text] [Related]
8. α-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applications. Sun H; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z Biomacromolecules; 2011 Jun; 12(6):1937-55. PubMed ID: 21469742 [TBL] [Abstract][Full Text] [Related]
9. Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design. Ogle ME; Segar CE; Sridhar S; Botchwey EA Exp Biol Med (Maywood); 2016 May; 241(10):1084-97. PubMed ID: 27229903 [TBL] [Abstract][Full Text] [Related]
10. Mechanical and biological properties of keratose biomaterials. de Guzman RC; Merrill MR; Richter JR; Hamzi RI; Greengauz-Roberts OK; Van Dyke ME Biomaterials; 2011 Nov; 32(32):8205-17. PubMed ID: 21835462 [TBL] [Abstract][Full Text] [Related]
11. Interplay between biomaterials and the immune system: Challenges and opportunities in regenerative medicine. Salthouse D; Novakovic K; Hilkens CMU; Ferreira AM Acta Biomater; 2023 Jan; 155():1-18. PubMed ID: 36356914 [TBL] [Abstract][Full Text] [Related]
13. Some properties of keratin biomaterials: kerateines. Hill P; Brantley H; Van Dyke M Biomaterials; 2010 Feb; 31(4):585-93. PubMed ID: 19822360 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of chitosan and its derivatives in regenerative medicine. Shi C; Zhu Y; Ran X; Wang M; Su Y; Cheng T J Surg Res; 2006 Jun; 133(2):185-92. PubMed ID: 16458923 [TBL] [Abstract][Full Text] [Related]
15. Diversification and enrichment of clinical biomaterials inspired by Darwinian evolution. Green DW; Watson GS; Watson JA; Lee DJ; Lee JM; Jung HS Acta Biomater; 2016 Sep; 42():33-45. PubMed ID: 27381524 [TBL] [Abstract][Full Text] [Related]
16. Shear-aggregated fibronectin with anti-adhesive properties. Branford OA; Brown RA; McGrouther DA; Grobbelaar AO; Mudera V J Tissue Eng Regen Med; 2011 Jan; 5(1):20-31. PubMed ID: 20652877 [TBL] [Abstract][Full Text] [Related]
17. Key players in the immune response to biomaterial scaffolds for regenerative medicine. Chung L; Maestas DR; Housseau F; Elisseeff JH Adv Drug Deliv Rev; 2017 May; 114():184-192. PubMed ID: 28712923 [TBL] [Abstract][Full Text] [Related]
18. Controlling cell behavior through the design of polymer surfaces. Alves NM; Pashkuleva I; Reis RL; Mano JF Small; 2010 Oct; 6(20):2208-20. PubMed ID: 20848593 [TBL] [Abstract][Full Text] [Related]